Since there has been no recent reassessment of many genera (Uhl and Dransfield 1987), it is difficult to give the real number of species within a genus, or, consequently, the total number of species occurring in Amazonia. This is likely to be lower in the largest genera, such as Bactris...
For targeted vaccination, cost effectiveness was highly dependent on the risk of infection. Incidence, vaccine cost and discount rate were the most influential parameters in sensitivity analyses. Overall, analyses that evaluated the combined hepatitis A/hepatitis B vaccine, adjusted incidence for under-...
作者: R. Jake Jacobs, MPA,Gene A. Gibson, PharmD,Allen S. Meyerhoff, MS 摘要: To determine the cost-effectiveness of substituting hepatitis A–B vaccine for hepatitis B vaccine when healthcare and public safety workers in the western United States are immunized to protect against occupational...
Hepatitis B vaccine has been progressively introduced into the Gambian programme of immunization since 1986. Other African countries are considering introduction but require evidence of cost-effectiveness to justify such a decision. The cost of the Expanded Programme on Immunization in The Gambia, which...
Cost- effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies. PharmacoEconomics 2008;26(1):17-32.Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, et al. Cost- ...
Instead, the B-cell epitopes of HEV have been mapped biochemically using recombinant capsid proteins or overlapping peptides. Using these analyses, a recombinant hepatitis E vaccine — the first human vaccine — was designed and created using an E. coli expression system [6•,7••]. The...
Indications for Use of Hepatitis B Vaccine, Based on Cost-Effectiveness Analysis To formulate indications for the use of hepatitis B vaccine, we examined the cost effectiveness of three strategies: vaccinating everyone; screening everyo... AG Mulley,MD Silverstein,JL Dienstag - 《New England Journal...
Hepatitis E is an important cause of morbidity and mortality in young adults in developing countries, and is particularly dangerous in pregnant women. Through recombinant technology a hepatitis E vaccine has been developed; in its first clinical trials the vaccine was found to be safe and immunogeni...
Conclusion The total cost of the hepatitis B vaccine immunization program in Beijing was increasing reasonably, with a greater increment ratio of manpower cost, from 1992 to 2013. The cost-effectiveness of HB vaccine immunization in relation to HB-related liver cancer incidence rate is generally sa...
Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nati... Davaalkham,Ojima,Wiersma,... - 《Journal of Epidemiology & Community Health》 - 2007 - 被引量: 37 Protective Efficacy of a Recombinant...